• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维持性血液透析患者中脂肪肝疾病与非致死性心血管事件的关联

Association of fatty liver disease with nonfatal cardiovascular events in patients undergoing maintenance hemodialysis.

作者信息

Lai Yu-Cheng, Cheng Ben-Chung, Hwang Jyh-Chang, Lee Yueh-Ting, Chiu Chien-Hua, Kuo Li-Chueh, Chen Jin-Bor

机构信息

Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan, ROC.

出版信息

Nephron Clin Pract. 2013;124(3-4):218-23. doi: 10.1159/000357952. Epub 2014 Feb 4.

DOI:10.1159/000357952
PMID:24503573
Abstract

BACKGROUND/AIMS: The prevalence of cardiovascular (CV) disease in patients undergoing maintenance hemodialysis (HD) is reportedly higher than that in healthy individuals. In the present study, we aimed to investigate whether ultrasonographically documented fatty liver disease (FLD) is an independent risk factor for nonfatal CV events in patients undergoing HD.

METHODS

A retrospective cohort study was conducted in a medical center in southern Taiwan. The medical records of 490 patients undergoing HD who were enrolled between July 1998 and October 2012 were screened. Finally, 278 patients who had undergone hepatic ultrasonography and had available data were recruited in the present study. The patients included 130 men and 148 women; their mean age was 59.9 years. The primary endpoint was nonfatal CV events in the observation period. The comparable data included epidemiological, hematological, and biochemical profiles. A time-dependent statistical method was used to analyze the associated factors.

RESULTS

The prevalence of nonfatal CV events was significantly increased in the patients with FLD compared with those without FLD (CV events: 32 vs. 18%, respectively; p = 0.008). After adjusting for associated risk factors (sex, age, body mass index, smoking, diabetes, hypertension, dyslipidemia, and Kt/V), multivariate analyses identified FLD (CV events: hazard ratio 2.84, 95% confidence interval 1.52-5.28, p = 0.001), advanced age, and diabetes to be independently associated with nonfatal CV events.

CONCLUSION

The study suggests that FLD was an independent risk factor for nonfatal CV events in patients undergoing maintenance HD.

摘要

背景/目的:据报道,维持性血液透析(HD)患者心血管(CV)疾病的患病率高于健康个体。在本研究中,我们旨在调查超声记录的脂肪肝疾病(FLD)是否是HD患者非致命性CV事件的独立危险因素。

方法

在台湾南部的一家医疗中心进行了一项回顾性队列研究。筛选了1998年7月至2012年10月期间登记的490例接受HD治疗的患者的病历。最终,本研究招募了278例接受肝脏超声检查并具有可用数据的患者。患者包括130名男性和148名女性;他们的平均年龄为59.9岁。主要终点是观察期内的非致命性CV事件。可比数据包括流行病学、血液学和生化特征。采用时间依赖性统计方法分析相关因素。

结果

与无FLD的患者相比,FLD患者非致命性CV事件的患病率显著增加(CV事件:分别为32%和18%;p = 0.008)。在调整相关危险因素(性别、年龄、体重指数、吸烟、糖尿病、高血压、血脂异常和Kt/V)后,多变量分析确定FLD(CV事件:风险比2.84,95%置信区间1.52 - 5.28,p = 0.001)、高龄和糖尿病与非致命性CV事件独立相关。

结论

该研究表明,FLD是维持性HD患者非致命性CV事件的独立危险因素。

相似文献

1
Association of fatty liver disease with nonfatal cardiovascular events in patients undergoing maintenance hemodialysis.维持性血液透析患者中脂肪肝疾病与非致死性心血管事件的关联
Nephron Clin Pract. 2013;124(3-4):218-23. doi: 10.1159/000357952. Epub 2014 Feb 4.
2
Inflammation, infection and cardiovascular events in chronic hemodialysis patients: a prospective study.慢性血液透析患者的炎症、感染与心血管事件:一项前瞻性研究。
J Nephrol. 2003 Mar-Apr;16(2):245-51.
3
Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: an open-label randomized controlled trial.血管紧张素受体阻滞剂对接受血液透析患者心血管事件的影响:一项开放标签随机对照试验。
Am J Kidney Dis. 2008 Sep;52(3):501-6. doi: 10.1053/j.ajkd.2008.04.031. Epub 2008 Jul 24.
4
Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes.非酒精性脂肪性肝病与1型糖尿病成年患者心血管疾病发病率增加独立相关。
Int J Cardiol. 2016 Dec 15;225:387-391. doi: 10.1016/j.ijcard.2016.10.040. Epub 2016 Oct 17.
5
Association of gait speed and grip strength with risk of cardiovascular events in patients on haemodialysis: a prospective study.血液透析患者的步态速度和握力与心血管事件风险的关联:一项前瞻性研究。
BMC Nephrol. 2019 May 30;20(1):196. doi: 10.1186/s12882-019-1370-6.
6
Prevalence and associated metabolic factors of fatty liver disease in the elderly.老年人脂肪肝的患病率及相关代谢因素。
Exp Gerontol. 2013 Aug;48(8):705-9. doi: 10.1016/j.exger.2013.05.059. Epub 2013 May 27.
7
Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.脑利钠肽在血液透析患者传统和非传统危险因素之间的作用:对两年随访中心血管死亡率的分析。
Nephron Clin Pract. 2011;119(2):c162-70. doi: 10.1159/000327615. Epub 2011 Jul 8.
8
Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non-alcoholic fatty liver.1 型糖尿病合并非酒精性脂肪肝患者慢性肾脏病患病率增加。
Diabet Med. 2012 Feb;29(2):220-6. doi: 10.1111/j.1464-5491.2011.03427.x.
9
A simple score predicts future cardiovascular events in an inception cohort of dialysis patients.一个简单的评分可预测透析患者起始队列中的未来心血管事件。
Kidney Int. 2006 Aug;70(3):543-8. doi: 10.1038/sj.ki.5001589. Epub 2006 Jun 14.
10
Left ventricular mass index and aortic arch calcification score are independent mortality predictors of maintenance hemodialysis patients.左心室质量指数和主动脉弓钙化评分是维持性血液透析患者独立的死亡预测指标。
Hemodial Int. 2012 Oct;16(4):504-11. doi: 10.1111/j.1542-4758.2012.00700.x. Epub 2012 Apr 22.

引用本文的文献

1
Oxidative stress and inflammation in hemodialysis: a comparison of patients with or without advanced nonalcoholic fatty liver disease (NAFLD).血液透析中的氧化应激与炎症:有无晚期非酒精性脂肪性肝病(NAFLD)患者的比较
Ren Fail. 2025 Dec;47(1):2455523. doi: 10.1080/0886022X.2025.2455523. Epub 2025 Jan 22.
2
Circulating vascular endothelial growth factor receptor 2 levels and their association with lipid abnormalities in patients on hemodialysis.血液透析患者循环血管内皮生长因子受体2水平及其与脂质异常的关系。
Biomed Rep. 2021 Apr;14(4):37. doi: 10.3892/br.2021.1413. Epub 2021 Feb 26.
3
The Association Between Nonalcoholic Fatty Liver Disease and Risk of Cardiovascular Disease, Stroke, and Extrahepatic Cancers.
非酒精性脂肪性肝病与心血管疾病、中风及肝外癌症风险之间的关联
J Clin Exp Hepatol. 2021 Jan-Feb;11(1):45-81. doi: 10.1016/j.jceh.2020.04.018. Epub 2020 May 20.
4
Systematic review of the impact of non-alcoholic fatty liver disease on mortality and adverse clinical outcomes for individuals with chronic kidney disease.非酒精性脂肪性肝病对慢性肾脏病患者死亡率和不良临床结局影响的系统评价
BMJ Open. 2020 Sep 28;10(9):e040970. doi: 10.1136/bmjopen-2020-040970.
5
Oxidative Stress and Nonalcoholic Fatty Liver Disease in Hemodialysis Patients.氧化应激与血液透析患者的非酒精性脂肪肝病。
Biomed Res Int. 2018 Nov 1;2018:3961748. doi: 10.1155/2018/3961748. eCollection 2018.
6
Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study.使用受控衰减参数联合超声检查血液透析患者的非酒精性脂肪性肝病:一项前瞻性队列研究。
PLoS One. 2017 Apr 20;12(4):e0176027. doi: 10.1371/journal.pone.0176027. eCollection 2017.
7
Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.非酒精性脂肪性肝病(NAFLD)——腹膜透析患者的一种新的心血管危险因素。
Perit Dial Int. 2016 Jul-Aug;36(4):427-32. doi: 10.3747/pdi.2014.00223. Epub 2015 Oct 16.
8
Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.非酒精性脂肪性肝病组织学谱中的心血管风险及临床表现:最新进展
World J Gastroenterol. 2015 Jun 14;21(22):6820-34. doi: 10.3748/wjg.v21.i22.6820.